Mepolizumab therapy improves endomyocarditis in seropositive eosinophilic granulomatosis with polyangiitis

被引：2
作者：
Wang, Chrong-Reen [1 ]
Tsai, Yi-Shan [2 ]
Lee, Cheng-Han [3 ]
机构：
[1] Natl Cheng Kung Univ Hosp, Div Rheumatol, Dept Internal Med, Tainan, Taiwan
[2] Natl Cheng Kung Univ Hosp, Dept Med Imaging, Tainan, Taiwan
[3] Natl Cheng Kung Univ Hosp, Div Cardiol, Dept Internal Med, Tainan, Taiwan
来源：
ARCHIVES OF RHEUMATOLOGY | 2023年 / 38卷 / 01期
关键词：
AMERICAN-COLLEGE; CHURG-STRAUSS; MANAGEMENT;
D O I：
10.46497/ArchRheumatol.2023.9559
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：159 / 161
页数：3
相关论文
共 50 条
  • [31] Myocarditis as the first manifestation of eosinophilic granulomatosis with polyangiitis
    Radojkovic, Danijela Djordjevic
    Apostolovic, Svetlana
    Damjanovic, Miodrag
    Kostic, Tomislav
    Levakov, Aleksandra Fejsa
    Dimitrijevic, Marko
    Tomasevic, Ruzica Jankovic
    Dakic, Sonja
    Bozinovic, Nenad
    Pavicevic, Milena
    VOJNOSANITETSKI PREGLED, 2023, 80 (11) : 942 - 948
  • [32] Eosinophilia: hypereosinophilic syndrome vs. eosinophilic granulomatosis with polyangiitis
    Holle, Julia U.
    Moosig, Frank
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2023, 82 (04): : 307 - 320
  • [33] Real-world mepolizumab treatment in eosinophilic granulomatosis with polyangiitis reduces disease burden in the United States
    Mathur, Sameer K.
    Silver, Jared
    Macknight, Sean D.
    Urosevic, Ana
    Martinez, Cristina
    Zhang, Kaixin
    Laliberte, Francois
    Deb, Arijita
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2025, 134 (03) : 341 - 350.e2
  • [34] Factors associated with drug retention of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: A multicentre REVEAL cohort study
    Shiomi, Mayu
    Watanabe, Ryu
    Matsuda, Shogo
    Kotani, Takuya
    Okazaki, Ayana
    Masuda, Yuichi
    Yoshida, Tsuneyasu
    Shoji, Mikihito
    Tsuge, Ryosuke
    Kadoba, Keiichiro
    Hiwa, Ryosuke
    Yamamoto, Wataru
    Takeda, Akitoshi
    Itoh, Yoshiaki
    Hashimoto, Motomu
    MODERN RHEUMATOLOGY, 2024, : 126 - 133
  • [35] Eosinophilic granulomatosis with polyangiitis present and future
    Mescia, Federica
    Egan, Allyson C.
    Cheema, Kim
    Sivasothy, Pasupathy
    Jayne, David R. W.
    RHEUMATOLOGY, 2021, 60 : 24 - 27
  • [36] Eosinophilic granulomatosis with polyangiitis, a case report
    Sturluson, Olafur Orri
    Palsson, Olafur
    Hjaltested, Einar
    Ludviksdottir, Dora
    LAEKNABLADID, 2024, 110 (01): : 28 - 32
  • [37] Eosinophilic Granulomatosis With Polyangiitis: A Case Report
    Robinson, Ciji
    Minhas, Jasdeep S.
    Kisule, Abraham
    Zebda, Hazem
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [38] Successful benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis
    Belfeki, N.
    Abroug, S.
    Ghriss, N.
    Chouchane, I
    Hamrouni, S.
    Strazzulla, A.
    Zayet, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (04) : 834 - 837
  • [39] Highlights from the plenary session: eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome
    Holle, Julia U.
    Vaglio, Augusto
    RHEUMATOLOGY, 2025, 64 : i92 - i97
  • [40] Eosinophilic granulomatosis with polyangiitis: myocardial thickening reversed by corticosteroids
    Mattsson, Gustav
    Magnusson, Peter
    BMC CARDIOVASCULAR DISORDERS, 2017, 17
12345